272 related articles for article (PubMed ID: 20029174)
1. Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines.
De Mattia D; Del Vecchio GC; Russo G; De Santis A; Ramenghi U; Notarangelo L; Jankovic M; Molinari AC; Zecca M; Nobili B; Giordano P;
Acta Haematol; 2010; 123(2):96-109. PubMed ID: 20029174
[TBL] [Abstract][Full Text] [Related]
2. Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica.
De Mattia D; Del Principe D; Del Vecchio GC; Jankovic M; Arrighini A; Giordano P; Menichelli A; Mori P; Zecca M; Pession A
Haematologica; 2000 Apr; 85(4):420-4. PubMed ID: 10756369
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
4. Management of adult idiopathic thrombocytopenic purpura.
Nakhoul IN; Kozuch P; Varma M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
[TBL] [Abstract][Full Text] [Related]
5. Management of acute childhood idiopathic thrombocytopenic purpura according to AIEOP consensus guidelines: assessment of Italian experience.
Del Vecchio GC; De Santis A; Giordano P; Amendola G; Baronci C; Del Principe D; Nobili B; Jankovic M; Ramenghi U; Russo G; Zecca M; De Mattia D;
Acta Haematol; 2008; 119(1):1-7. PubMed ID: 18176072
[TBL] [Abstract][Full Text] [Related]
6. Management of chronic immune thrombocytopenic purpura in children and adults.
Blanchette V; Freedman J; Garvey B
Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
8. Chronic immune thrombocytopenia in childhood.
Del Vecchio GC; De Santis A; Accettura L; De Mattia D; Giordano P
Blood Coagul Fibrinolysis; 2014 Jun; 25(4):297-9. PubMed ID: 24492401
[TBL] [Abstract][Full Text] [Related]
9. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
10. Intended management of children with acute idiopathic thrombocytopenic purpura: a national survey.
Marks MK; Vadamalayan B; Ekert H; South MJ
J Paediatr Child Health; 2005; 41(1-2):52-5. PubMed ID: 15670225
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute immune thrombocytopenic purpura.
Tarantino MD; Goldsmith G
Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
[TBL] [Abstract][Full Text] [Related]
12. Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000-2002: a retrospective analysis.
Cirasino L; Robino AM; Cattaneo M; Pioltelli PE; Pogliani EM; Terranova L; Morra E; Colombo P; Palmieri GA; Piscitelli P
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):77-84. PubMed ID: 19858712
[TBL] [Abstract][Full Text] [Related]
13. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP
Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
[TBL] [Abstract][Full Text] [Related]
15. How we use WinRho in patients with idiopathic thrombocytopenic purpura.
Stotler BA; Schwartz J
Transfusion; 2015 Nov; 55(11):2547-50. PubMed ID: 26094894
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura.
Kane I; Ragucci D; Shatat IF; Bussel J; Kalpatthi R
Br J Haematol; 2010 Apr; 149(1):79-83. PubMed ID: 20096011
[TBL] [Abstract][Full Text] [Related]
17. Treatment of immune thrombocytopenic purpura in adults.
Bussel J
Semin Hematol; 2006 Jul; 43(3 Suppl 5):S3-10; discussion S18-9. PubMed ID: 16815346
[TBL] [Abstract][Full Text] [Related]
18. A multicenter prospective study on the treatment of chronic idiopathic thrombocytopenic purpura.
Dan K; Gomi S; Kuramoto A; Maekawa T; Nomura T
Int J Hematol; 1992 Jun; 55(3):287-92. PubMed ID: 1498319
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
Freiberg A; Mauger D
Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
[TBL] [Abstract][Full Text] [Related]
20. Critical issues concerning splenectomy for chronic idiopathic thrombocytopenic purpura in childhood.
Minkov M
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):734-6. PubMed ID: 16933270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
